European Case Law Identifier: | ECLI:EP:BA:2014:T252210.20140128 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 28 January 2014 | ||||||||
Case number: | T 2522/10 | ||||||||
Application number: | 02029008.6 | ||||||||
IPC class: | C07K 1/18 C07K 16/32 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | A composition comprising anti-HER2 antibodies | ||||||||
Applicant name: | Genentech, Inc. | ||||||||
Opponent name: | Synthon B.V. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Exclusion from file inspection (no) 'Confidentiality club' in EPO proceedings (no) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102522eu2.html
Date retrieved: 17 May 2021